Host gene expression changes in cattle infected with Alcelaphine herpesvirus 1  by Russell, George C. et al.
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a  b  s  t  r  a  c  t
Malignant  catarrhal  fever  is  a lymphoproliferative  disease  of  cattle  and  other  ungulates  caused  by  infec-
tion with  gamma-herpesviruses  of  the  genus  Macavirus.  These  viruses  do  not  establish  a productive
infection  but  instead  replicate  in  a cell-associated  fashion  in T lymphocytes,  leading  to  systemic  immune
dysregulation  and  a  generally  fatal outcome.  Despite  signiﬁcant  progress  in  understanding  the pathology
of  this  disease,  its  pathogenesis  remains  unclear.
To  identify  genes  and  pathways  affected  in  clinical  MCF,  sixteen  bovine  GeneCHIP  microarrays  were
used  to assay  RNA  from  kidney  and  lymph  node  of  four  MCF-affected  and  four  control  Bos  taurus  steers.
This  is  the  ﬁrst  expression  study  of  AlHV-1-MCF  in the  bovine  host.  Over  250  genes  showed  signiﬁcant
changes  in  gene  expression  in  either  lymph  node  or kidney,  while  expression  of  35  genes  was  altered  in
both  tissues.  Pathway  and  annotation  analysis  of the  microarray  data  showed  that  immune  response  and
inﬂammatory  genes  were  up-regulated  in  the  kidney  while  proliferation-associated  transcripts  were
additionally  increased  in  the  lymph  node.  The  genes  that  showed  the  largest  expression  rises  in both
diseased  tissues  included  cytotoxic  enzymes  and  pro-inﬂammatory  chemokines.
These  data  are  consistent  with  disease-induced  stimulation  of  inﬂammatory  responses  involving
interferon-,  including  cytotoxic  T  cell  recruitment  and  activation  in  peripheral  tissues  containing  virus-
infected  cells.  However  it remains  unclear  whether  the  tissue  damage  in  MCF  lesions  is  due  entirely to
the activity  of  infected  cells  or whether  uninfected  T  cells,  recruited  and  activated  at lesion  sites  through
s,  conthe  action  of infected  cell
. Introduction
Malignant catarrhal fever (MCF) is a dramatic, fatal disease of
attle and other ungulates, including deer, bison and pigs, caused
y ruminant gamma-herpesviruses of the genus Macavirus includ-
ng Alcelaphine herpesvirus 1 (AlHV-1) and Ovine herpesvirus-2
OvHV-2) (Loken et al., 1998; Reid et al., 1984; Schultheiss et al.,
000). The disease is characterised by fever and inappetence,
requently with ocular and nasal discharge, and is usually fatal.
eath can occur within a few days or up to several weeks after the
nset of clinical signs. There is no known treatment or licensed
accine for MCF  but a vaccine strategy to protect animals from
∗ Corresponding author. Tel.: +44 131 4456149; fax: +44 131 4456111.
E-mail addresses: george.russell@moredun.ac.uk (G.C. Russell),
.benavides@eae.csic.es (J. Benavides), Dawn.Grant@moredun.ac.uk
D.M. Grant), Helen.Todd@moredun.ac.uk (H. Todd),
ackie.Thomson@moredun.ac.uk (J. Thomson), vipulpuri@ymail.com (V. Puri),
intu@bioss.ac.uk (M.  Nath), david.haig@nottingham.ac.uk (D.M. Haig).
1 Present address: Instituto de Ganaderia de Montan˜a (CSIC-ULE), 24346 Grulleros
Leon), Spain.
168-1702/© 2012 Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.virusres.2012.08.011
Open access under CC BY license.tribute  to the  pathogenesis  of  MCF.
© 2012 Elsevier B.V. 
MCF  caused by AlHV-1 has been described recently (Haig et al.,
2008; Russell et al., 2012).
AlHV-1 causes MCF  mainly in East Africa, following the range
of the wildebeest (Connochaetes taurinus), the natural host species,
which propagates the virus without apparent clinical signs (Russell
et al., 2009). Wildebeest-associated MCF  (WA-MCF) is a signiﬁ-
cant issue for pastoralists in Eastern and Southern Africa, where
cattle are moved to avoid contact with grazing or calving wilde-
beest (Bedelian et al., 2007; Cleaveland et al., 2001). WA-MCF
also has been a problem in zoological collections that contain
wildebeest (Meteyer et al., 1989; Whitaker et al., 2007). OvHV-2
naturally infects sheep and causes sheep-associated MCF (SA-MCF),
which is found worldwide wherever sheep and cattle (or other
MCF-susceptible species) are kept together. SA-MCF is a particu-
lar problem in North America where bison are highly susceptible
to infection (Berezowski et al., 2005).
An interesting feature of MCF  is that the natural reservoir species
Open access under CC BY license.for the viruses causing MCF  (e.g. wildebeest and sheep) do not
exhibit any clinical signs of infection, whereas the disease is dra-
matic and usually fatal in MCF-susceptible species, some of which
are phylogenetically closely related to the reservoir hosts. There
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re excellent animal models of MCF. In particular, rabbits can be
nfected with AlHV-1 or OvHV-2 and develop MCF that is very sim-
lar to that seen in species naturally susceptible to MCF  (Anderson
t al., 2007; Buxton et al., 1984). This model of MCF is now widely
sed in the analysis of MCF  pathogenesis, including analysis of
ecombinant AlHV-1 (Anderson et al., 2008; Boudry et al., 2007;
ewals et al., 2006, 2011, 2008; Li et al., 2011; Meier-Trummer
t al., 2009b).  Analysis of the pathology of MCF  induced by AlHV-1
nd OvHV-2 suggests an immune-mediated aetiology, with inﬁl-
ration/proliferation of lymphocytes in multiple tissues (Anderson
t al., 2007). Recent studies have suggested that the proliferating
ells are T cells and that many of these may  be infected (Dewals
t al., 2008; Nelson et al., 2010). Infected large granular lymphocyte
LGL) cell lines that can be propagated in culture from MCF-affected
nimals have a non-MHC-restricted cytotoxic T cell phenotype
imilar to lymphokine-activated killer cells and it has been sug-
ested that these cells cause the dramatic pathology seen in MCF
Anderson et al., 2008; Schock et al., 1998; Swa et al., 2001). The
xact aetiology of MCF  pathogenesis has yet to be elucidated.
The involvement of virus gene expression in disease progres-
ion has been studied mainly in the rabbit model, where different
onclusions have been drawn in different studies. Thus, studies of
vHV-2 infection by intra-nasal or intravenous inoculation have
emonstrated lytic cycle-associated gene or protein expression in a
ange of tissues (Li et al., 2011; Meier-Trummer et al., 2009b), while
nalysis of lymphoid tissues from rabbits infected intravenously
ith AlHV-1 has shown a latency-associated gene expression pat-
ern (Dewals et al., 2011, 2008). The inability of either virus to
roduce infectious virus particles in MCF-susceptible species also
uggests that the full programme of lytic virus gene expression is
ot completed in these hosts. Thus the virus may  be limited to
ome form of latency or to an aberrant pattern of gene expres-
ion that is abortive for virus propagation. Analysis of LGL from
attle and rabbits infected with OvHV-2 showed that these cells
ontained circular (latent) genomes and did not express known
ytic cycle transcripts, although some viral gene expression was
etected (Thonur et al., 2006). The conﬂicting evidence of recent
tudies may  also suggest that virus gene expression patterns can
ary depending on host species and cell type infected.
Virus-speciﬁc and bovine genome microarrays have been used
ecently to identify virus and host genes whose expression was
ltered in lymph node tissue of two cattle naturally infected with
vHV-2 (Meier-Trummer et al., 2009a).  This study found that virus
nfected cells in MCF-affected cattle had a latent pattern of gene
xpression; that cytotoxicity and cell-cycle associated genes were
p-regulated; and notably that IL-2 expression was  reduced by
bout 7-fold on average. Other work has suggested the involve-
ent of IL-15 in the proliferation and cytotoxic activity of infected
ells in AlHV-1 induced MCF  (Anderson et al., 2008) but the crucial
actors in MCF  pathogenesis have yet to be conﬁrmed in vivo.
Recent work in this laboratory has led to the development of an
ntranasal route for infection of cattle with AlHV-1 that produces
eliable induction of MCF. This has been used in the development
f a protective vaccine strategy for MCF  in cattle (Haig et al., 2008;
ussell et al., 2012) and has provided tissues for detailed analysis
f MCF  pathology (J. Benavides, H. Todd, G.C. Russell, D.M. Haig,
npublished data). In this paper we describe the use of lymphoid
nd non-lymphoid tissues from this natural infection of MCF  to
haracterise patterns of gene expression involved in disease patho-
enesis. Host gene expression changes due to MCF  were identiﬁed
sing RNA extracted from kidney and prefemoral lymph node tis-
ue samples from infected and uninfected cattle. The kidney was
sed as it represents the cellular pathological changes seen in
on-lymphoid tissues in MCF-affected animals. Uninfected kidney
ontains few lymphoid cells, so the infected tissue may  reveal MCF-
peciﬁc effects that are not distinguished in lymphoid tissue, wherech 169 (2012) 246– 254 247
the background of lymphoid cells not involved directly in MCF  may
confound transcriptional analysis. Microarray analysis was used
to provide data on approximately 23,000 genes and bioinformatic
analysis was used to identify signiﬁcantly affected genes (up- or
down-regulated compared to control samples), functional classes
and pathways, shedding light on potential mechanisms of patho-
genesis.
This is the ﬁrst report of gene transcription analysis in a natu-
ral disease-susceptible species (cattle) infected with AlHV-1. This
should allow any differences and similarities to AlHV-1-infected
rabbits or OvHV-2-infected cattle to be revealed.
2. Materials and methods
2.1. Animals and tissues
The animal experiments were carried out with the approval of
the Moredun Research Institute Experiments and Ethical Review
Committee and complied fully with the Home Ofﬁce of Great Britain
and Northern Ireland “Animals (Scientiﬁc Procedures) Act 1986”.
Disease-free and OvHV-2 seronegative male Friesian-Holstein
cross calves between 3 and 5 months of age were used. One  group
of seven cattle was  infected intranasally with 104.55 TCID50/ml (50%
tissue culture infectious dose) of pathogenic AlHV-1 as described
previously (Haig et al., 2008; Russell et al., 2012) while a control
group of four animals was left uninfected. The cattle were moni-
tored daily and animals exhibiting a rise in rectal temperature to
over 40 ◦C for at least 2 days with other clinical signs consistent with
MCF  (inappetence and ocular signs or palpable lymphadenopathy)
were euthanised with an overdose of intravenous sodium pento-
barbitone. Diagnosis of MCF  in these animals was conﬁrmed by
gross and histopathological examination of tissue samples and by
diagnostic PCR detection (Traul et al., 2005) of AlHV-1 DNA in blood
samples taken at post-mortem. Samples of prefemoral lymph node
(LN) and renal cortex (Kid) were collected asceptically from four
infected and four control animals and were stored at −20 ◦C in
RNAlater (Life Technologies) as cubes smaller than 5 mm.
2.2. RNA extraction and microarrays
Tissue samples of about 100 mg  from control uninfected
and MCF  affected cattle were used for RNA preparation
using Trizol reagent and a silica-based RNA puriﬁcation sys-
tem (Qiagen) according to the protocol of ARK-genomics
(www.ark-genomics.org). RNA samples from both tissues of 4
MCF-affected and 4 control animals that passed the RNA quality
criteria (A260/280 ratio = 2.0 ± 0.05; RNA integrity number (RIN) > 7.0
as assessed using the Eukaryotic RNA 6000 LabChip kit on the
Agilent 2100 Bioanalyser) were submitted to ARK-genomics for
microarray analysis using Affymetrix GeneChip® Bovine Genome
Arrays, representing about 23,000 transcripts.
2.3. Data processing
The data were pre-processed using the MAS  5.0 background
adjustment method as outlined in the Affymetrix Statistical
Algorithms Description Document (http://media.affymetrix.
com/support/technical/whitepapers/sadd whitepaper.pdf). To
make measurements from different arrays comparable, data were
normalised by the quantile normalisation method (Bolstad et al.,
2003). Quality assessments of probe-level Affymetrix chip data
as well as normalised data were carried out using statistical and
graphical methods including MA  plots and smoothed histogram
plots. The MA-plots showed normalisation was effective; while
smoothed histograms indicated there was  no systematic bias in
the data. The smallest statistically signiﬁcant difference in mean
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xpression level between affected and control microarrays was
bout 1.3-fold, demonstrating the reliability of the microarray data
resented here. The raw and normalised data from this experiment
ave been submitted to the ArrayExpress database and have been
ssigned the accession number E-MEXP-3497.
.4. Gene expression analysis
Gene expression measurements were managed following the
IAME  standard (Brazma et al., 2001). A general linear model
as ﬁtted to the normalised expression data for differential
xpression analysis. The coefﬁcients of the ﬁtted models corre-
ponded to two types of RNA sources (tissue type: kidney and
ymph node; treatment type: MCF-affected and control). The test
tatistic for each gene was the moderated t-statistic, where the
tandard error used to calculate the t-statistic was estimated
sing the posterior obtained from an empirical Bayesian model
Smyth, 2004). The overall signiﬁcance of each test was adjusted
sing the false discovery rate (FDR) approach of Benjamini and
ochberg (1995).  All analyses were carried out using the Bio-
onductor suite of programs under the R 2.10.1 environment
www.r-project.org). Probesets with statistically signiﬁcant dif-
erences in mean expression (FDR-adjusted p, pf < 0.01 and mean
old-change (FC) > 2.0) in MCF-affected versus control tissues were
dentiﬁed as being suitable for further analysis. These probesets
ere further analysed using the Ingenuity Pathways Analysis (IPA)
ystem (www.ingenuity.com) and the DAVID online software sys-
em (Huang et al., 2008).
.5. Real-time quantitative PCR of selected genes
Three host genes with signiﬁcant up-regulation of expres-
ion in MCF-affected animals and two genes with no evidence
f expression change were selected for real-time PCR conﬁrma-
ion of microarray data. RNA extracted from MCF-affected and
ontrol tissues for microarray analysis was also used for these
ssays to facilitate comparison. The real-time PCR primer and probe
ets for each gene were designed using Primer Express software
Applied Biosystems, Warrington, UK) (Table 1). Where possi-
le, primer-probe sets were designed to span exons within the
espective genes to reduce detection of genomic DNA contami-
ation of RNA. All primers and probes were designed within a
arrow annealing temperature range to facilitate the optimisa-
ion of the PCR and the simultaneous analysis of multiple genes.
rimer and probe optimisation was done according to the instru-
ent manufacturer’s protocols, using a chequerboard of forward
nd reverse primer concentrations and titration of probe concen-
ration. Concentrations of primers (900 nM)  and probes (250 nM)
hat gave the lowest threshold cycle (Ct) values and highest ﬂu-
rescence yield (Rn) across a range of concentrations of pooled
NA template were used in all subsequent assays. The real-time
uantitative (q)RT-PCR was carried out using the Superscript III
latinum One-Step qRT-PCR kit (Life Technologies). Reactions of
0 l each contained: 10 l of 2× Reaction Mix; 2.0 l of each
 M primer; 1.0 l of 5 M probe; 4.0 l PCR grade DNase-free
ater and 1.0 l (100 ng) total RNA. Prior to analysis, RNA samples
ere treated with ampliﬁcation-grade DNAse I (Life Technologies)
o reduce background ampliﬁcation due to genomic DNA contami-
ation. All reactions were carried out on a Roche LightCycler (Roche
pplied Science) with the following cycling parameters: 50 ◦C for
5 min  and 95 ◦C for 2 min  followed by 40 cycles of 95 ◦C for 15 s and
0 ◦C for 30 s. Data were analysed using LightCycler 480 software
version LCS480 1.5.0.39).
Additionally, parallel control ampliﬁcations were performed on
ach RNA sample in the absence of a reverse transcription step toch 169 (2012) 246– 254
conﬁrm that genomic DNA contamination did not contribute to the
ampliﬁcation seen.
Bovine ribosomal protein S9 (RPS9) was chosen as the reference
gene for these studies because its mean expression was  not statisti-
cally signiﬁcantly altered in either tissue in response to MCF  in the
microarray study. The use of this gene as a gene expression standard
has also been validated in multiple cattle tissues under different
metabolic conditions (Bionaz and Loor, 2007; Janovick-Guretzky
et al., 2007) and in neoplastic versus normal tissues (Blanquicett
et al., 2002).
Analysis of gene expression was  performed by relative quan-
tiﬁcation, normalised to the reference gene RPS9, using the Ct
method as described (Schmittgen and Livak, 2008). Brieﬂy, mean
Ct values were derived from replicate assays for each gene and
sample (tissues: lymph node and kidney; conditions: MCF and con-
trol). Next, for each gene, tissue and condition the mean Ct for the
RPS9 reference gene was subtracted from the mean Ct for each
gene assayed, giving a Ct value for that gene/tissue/condition.
The Ct values for the control group were then subtracted from the
respective MCF  Ct values for each gene and tissue, giving a Ct
value that represented the fold-change between MCF  and control
animals. Finally, the actual fold-change values between MCF  and
control samples for each gene and tissue were calculated as 2−Ct.
3. Results
3.1. Induction of MCF
All animals in the group inoculated intranasally with pathogenic
AlHV-1 showed clinical signs of MCF  at 27–30 days post-infection.
The animals were euthanised on the second or third day of pyrexia,
with additional clinical signs consistent with MCF  (conjunctivitis or
lymphadenopathy). The diagnosis of clinical MCF  was conﬁrmed by
gross and histopathological ﬁndings and by the detection of AlHV-1
virus DNA in blood and tissue samples. Histologically, the kidney
from the infected animals showed multifocal interstitial nephri-
tis characterised by non-purulent vasculitis, mainly affecting the
arcuate vessels although lesions were also visible in other minor
veins and arteries. The lymph node from these animals showed
a diffuse follicular lymphoid hyperplasia. Samples from the non-
infected animals showed no gross or histological lesions. No clinical
signs were seen in the control animals, which were subject to post-
mortem examination separately from the MCF-affected animals.
3.2. Identiﬁcation of differentially expressed genes in
MCF-affected tissues
Analysis of gene expression in two  tissues from four animals
each in control or MCF-affected groups was done using a single-
dye approach on 16 Affymetrix GeneChip Bovine Genome Arrays
(www.affymetrix.com/analysis/index.affx). RNA for microarray
analysis was extracted from tissue samples using a standard pro-
tocol and was stored in aliquots at −80 ◦C. Assessment of RNA
integrity by capillary electrophoresis ensured that all RNA used for
this analysis was of a similar high quality. The RNA samples sub-
mitted for microarray analysis had concentrations between 1.1 and
2.3 mg/ml, A260/280 ratios of 2.00–2.02 and RIN values of 7.4–8.9.
Analysis of hybridisation intensity data after background adjust-
ment and normalisation showed that there was  little systematic
bias in the observed data.
The array data for each set of four samples was combined and
used to identify probesets with statistically signiﬁcantly different
mean expression levels between control and MCF-affected sam-
ples within each tissue (p-value adjusted for false discovery rate
(FDR), pf < 0.01). Over 1350 probesets were statistically signiﬁcantly
G.C. Russell et al. / Virus Research 169 (2012) 246– 254 249
Table 1
Primer and probe sequences used for quantitative PCR.
Gene symbol Oligonucleotide sequence (5′–3′) Accession number of cDNA
RPS9-F GCCTCGACCAAGAGCTGAAG DT860044
RPS9-R GGGCAGCCTTTCGGATCT
RPS9-P FAM-TGATCGGCGAGTATGGGCTCCG-TAMRA
G6PI-F CATTGCCTCCAAGACCTTCAC NM 001040471
G6PI-R GGCCGACAGGAGAAACC
G6PI-P TET-ACCCAGGAGACCATCACGAACGCA-TAMRA
GNLY-F TGGGCTGTCCTGCTCATCA NM 001075143
GNLY-R TCAGGAGTCAGACCGGAAAAA
GNLY-P TET-CTCGGTGCTCCTGGTTGCCCC-TAMRA
GRNZH-F GCTGGGAGAGGAGATCATTGG XM 002696688
GRNZH-R CAGAAACTGAACGAAAGCCATGT
GRNZH-P TET-CCAAGCCCCACTCCCGCCC-TAMRA
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using the Ct method (Schmittgen and Livak, 2008).
These results (Fig. 1) veriﬁed the up-regulation of GNLY and
GZMH, which showed greater than 5-fold increases in mean
expression in both tissues, and suggested that expression of
16.0
32.0
64.0
128.0
256.0
0.5
1.0
2.0
4.0
8.0
GZMHGZMBGNLYGPI
Fo
ld
 c
ha
ng
e 
ex
pr
es
sio
n 
in
 M
CF
Fig. 1. Gene expression fold-change values derived from qPCR data. The changes inGRNZB-F GTAGGTGCGGTGGGTTCCT 
GRNZB-R TTGATTGAGCTTCCGTTGCA
GRNZB-P TET-TCGACAGGACTTCGTGCTGACAGCC-
ltered in lymph node while more than 760 were found to be sta-
istically signiﬁcantly altered in kidney. Of these, 197 probesets in
ymph node and 291 probesets in the kidney had average fold-
hange differences of more than 2. These probesets corresponded
o 269 currently annotated genes of which 69 genes were up-
egulated by at least 2-fold on average in lymph node compared
ith 161 genes in the kidney; while 52 genes showed at least 2-fold
verage down-regulation in the lymph node compared to only 22
enes in the kidney (supplementary Table S1).  Interestingly, only
5 genes showed altered expression in both tissues (Table 1), of
hich 32 genes were up-regulated. This observation suggests that
CF  may  induce tissue-speciﬁc changes in gene expression.
The observation that most of the genes with altered regulation
n both tissues increased in expression during MCF  suggests the
nduction of a core gene set that may  be illustrative of the major
hanges in gene expression that occur in MCF  (Table 2). Of this
roup of genes, those with the greatest degree of change included:
ranulysin (GNLY); granzyme H (GZMH); chemokine (C–X–C motif)
igand 11 (CXCL11); ubiquitin D (UBD); chemokine (C–C motif) lig-
nds 3, 4 and 5 (CCL3, CCL4 and CCL5); the CD8 alpha chain (CD8a);
lacenta-speciﬁc 8 (PLAC8); and indoleamine 2,3-dioxygenase 1
IDO1). All of these genes have known functions relating to regu-
ation of immune responses and may  therefore have roles in the
mmune dysregulation that characterised MCF.
In contrast, only 3 genes were found to show more than 2-
old reduced expression in both tissues of MCF-affected animals.
hese genes: cold inducible RNA binding protein (CIRBP); stromal
ntigen 3 (STAG3); and RNA binding motif protein 3 (RBM3) have
nown functions related to chromosome pairing (STAG3) and the
esponse to metabolic insults (e.g. cold). These differences may  be a
onsequence of MCF, driven either by pathogenic processes or the
nti-viral response, but their potential role in disease is unclear. In
rder to integrate the contributions of multiple genes to MCF  patho-
enesis and potentially identify biological processes or pathways
hat may  be co-regulated in the diseased tissues, global analysis of
p- and down-regulated genes was performed using two  systems
ith distinct approaches.
.3. Quantitative PCR analysis of gene expression changes
Real-time quantitative (q)PCR was used as an independent assay
o verify that the microarray analysis had correctly identiﬁed genes
ith signiﬁcant expression changes between control and MCF-
ffected tissues. Five genes were selected for analysis on the basis
f microarray data and qPCR primer-probe sets were designed for
ach gene (Table 1). Two genes were selected with the highestXM 002696646
A
expression change in both tissues (GNLY, GZMH; Table 2); two
genes were selected that had unchanged expression (glucose-6-
phosphate isomerise (GPI), RPS9); and one gene was selected that
had a high level expression change in one tissue (granzyme B
(GZMB); supplementary Table S1). No genes with reduced expres-
sion were selected for analysis by this method as the expression
change in these genes (2–3-fold reduction) was considered to be
too low to reliably distinguish by real-time PCR (Table 2).
For this analysis RPS9 was  selected as the reference gene because
it had previously been validated for quantitative analysis in bovine
tissues (Bionaz and Loor, 2007) and it exhibited little variation in
the microarray analysis (mean fold-change in MCF-affected tissue
was  1.03 in kidney and 1.07 in lymph node with pf values of 0.84
and 0.54 respectively). Quantitative PCR analysis of RPS9 expres-
sion in the tissues examined (kidney and lymph node; infected and
control) revealed low levels of variation. Ct values for assays of
equivalent amounts of total RNA had a standard deviation of less
than 1 cycle, supporting the use of RPS9 as a reference gene in this
analysis. RNA samples were assayed in duplicate or triplicate and
mean Ct values were used to calculate fold-change differences in
expression of the selected genes between MCF  and control tissuesexpression of four genes: glucose-6-phosphate isomerase (GPI); granulysin (GNLY);
granzyme B (GZMB); and granzyme H (GZMH) in MCF-affected tissues were nor-
malised to ribosomal protein S9 (RPS9) and plotted with respect to equivalent tissues
from  control animals. Results of kidney transcript assays are in the light columns
while results of lymph node assays are in the dark columns.
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Table 2
Known genes with at least 2-fold change between MCF-affected and control tissues.
Gene symbola Gene titleb K (FC)c K (pf)d LN (FC) LN (pf)
(A) Genes signiﬁcantly up-regulated in both tissues of MCF-affected animals
GNLY Granulysin (mean)e 8.9 0.0009 16.5 0.0002
GZMH Granzyme H 10.2 <0.0001 15.1 <0.0001
CXCL11 Chemokine (C–X–C motif) ligand 11 14.3 0.0001 8.4 0.0009
UBD  Ubiquitin D (mean) 13.8 <0.0001 3.2 0.0080
CCL4  Chemokine (C–C motif) ligand 4 8.8 <0.0001 4.8 0.0002
CD8A CD8a molecule 7.2 <0.0001 2.4 0.0007
CCL5 Chemokine (C–C motif) ligand 5 5.9 <0.0001 3.1 0.0002
PLAC8 Placenta-speciﬁc 8 (mean) 5.8 0.0001 5.6 0.0014
IDO1 Indoleamine 2,3-dioxygenase 1 (mean) 5.5 0.0001 4.9 0.0004
CCL3  Chemokine (C–C motif) ligand 3 (mean) 4.9 <0.0001 3.0 0.0008
OASL  2′–5′-oligoadenylate synthetase-like 2.2 0.0058 3.8 0.0003
HOPX  HOP homeobox 3.7 <0.0001 3.1 0.0004
FCGR3A Low afﬁnity Fc receptor IIIa, IgG (CD16a) 3.5 <0.0001 2.2 0.0011
WARS Tryptophanyl-tRNA synthetase (mean) 3.5 <0.0001 2.3 0.0009
IFNG Interferon, gamma  3.0 0.0024 3.3 0.0016
RRM2 Ribonucleotide reductase M2  polypeptide 3.2 0.0010 2.6 0.0048
PRF1 Perforin 1 (pore forming protein) 3.1 <0.0001 2.4 0.0006
CKS2  CDC28 protein kinase regulatory subunit 2 2.5 0.0015 3.1 0.0005
SH2D1A SH2 domain protein 1A 3.0 <0.0001 2.7 0.0004
MTHFD2 Methylenetetrahydrofolate dehydrogenase 2 2.8 0.0003 2.3 0.0006
LMNB1 Lamin B1 2.3 0.0047 2.8 0.0010
CCR5  Chemokine (C–C motif) receptor 5 2.5 0.0001 2.5 0.0005
PPA1  Pyrophosphatase (inorganic) 1 2.5 0.0002 2.4 0.0006
NCAPG Non-SMC condensin I complex, subunit G 2.5 0.0006 2.1 0.0029
ISG20  Interferon stimulated exonuclease gene 20 kDa 2.5 0.0012 2.4 0.0016
CDCA8 Cell division cycle associated 8 2.5 0.0005 2.2 0.0017
NUSAP1 Nucleolar and spindle associated protein 1 2.4 0.0021 2.1 0.0057
CD96  CD96 molecule 2.4 0.0003 2.4 0.0006
TOP2A Topoisomerase (DNA) II alpha 170 kDa (mean) 2.4 0.0077 2.1 0.0090
UBE2C Ubiquitin-conjugating enzyme E2 C 2.3 0.0004 2.2 0.0009
CCNB2 Cyclin B2 2.1 0.0051 2.1 0.0032
CRELD2 Cysteine-rich with EGF-like domains 2 2.0 0.0070 2.1 0.0048
Gene  symbol Gene name K (1/FC)f K (pf) LN (1/FC) LN (pf)
(B) Genes signiﬁcantly down-regulated in both tissues of MCF-affected animals
CIRBP Cold inducible RNA binding protein 3.3 <0.0001 3.3 0.0002
STAG3 Stromal antigen 3 (mean) 2.5 0.0001 2.5 0.0004
RBM3 RNA binding motif protein 3 (mean) 2.0 0.0008 2.5 0.0002
a Gene identities for probesets from the Affymetrix GeneChip Bovine Genome Arrays were obtained from the NetAffxTM Analysis Center (www.affymetrix.com/
analysis/index.affx)  or were assigned following sequence-based database searching.
b Genes are ordered on the basis of their maximal expression change in either tissue.
c Fold-change in gene expression (FC) in MCF  compared to control tissue, and p-values adjusted for false discovery rate (pf) are listed for kidney (K) and lymph node (LN)
samples.
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and autoimmunity) suggesting active immune responses and pro-
liferation. Annotations enriched among down-regulated genes ind False discovery rate adjusted p-values (pf) are expressed with 4-decimal precisi
e Where multiple probesets representing the same gene were signiﬁcantly altered
he  pf value shown is the highest of the probesets analysed.
f Degree of down-regulation is expressed as the inverse of the fold-change (1/FC
ZMB was also increased in both tissues. From the microar-
ay data for the gene GZMB, a statistically signiﬁcant change in
he mean expression level was found in the lymph node (FDR-
djusted probability, pf = 0.0001). In addition, the pf value of 0.028
rovided weak evidence for an altered mean expression level
f GZMB in kidney (fold change of 2.5). Although this did not
ttain formal statistical signiﬁcance as deﬁned by the chosen
hreshold of pf < 0.01, it provided some support for the real-
ime PCR results suggesting that GZMB was up-regulated in both
issues.
The fold-change estimated by real-time PCR for GNLY, GZMB
nd GZMH was greater than that suggested by the microarray
ata, especially for the kidney RNA samples. This is in accord with
omparative analyses, which observed that fold change results
etermined by qRT-PCR were greater than those determined by
icroarray analysis (Dallas et al., 2005; Yuen et al., 2002). Expres-
ion of the housekeeping gene GPI, in contrast to the cytotoxic genes
NLY, GZMH and GZMB, was not affected by MCF, varying by less
han 2-fold in either tissue (Fig. 1).
These data support the view that the microarray analysis was
ble to correctly identify signiﬁcant changes in gene expression
ue to MCF.pression, the FC value given is the mean, indicated in the gene name column, while
3.4. Analysis of enriched gene ontology terms in differentially
expressed genes
The on-line database system DAVID (Huang et al., 2008, 2009)
was  used to identify gene ontology terms, functional classes and
pathways that were enriched among the differentially expressed
genes in each tissue. This analysis is summarised in Table 3. DAVID
analysis uses only gene identiﬁers, so separate datasets for up-
and down-regulated genes were analysed for each tissue, compris-
ing those genes with pf < 0.01 and mean fold-change (FC) greater
than 2. Highly enriched annotation terms among up-regulated
genes in the kidney included: antigen presentation; inﬂamma-
tory responses; immune regulation and activation. These processes
were also reﬂected in up-regulated pathways such as antigen
presentation, graft rejection and graft-versus-host disease, all sug-
gestive of increased immune activity in this tissue (Table 3). This
contrasts with the enriched terms relating to up-regulated genes in
the lymph node (cell division and mitosis in addition to chemokineskidney were fewer in number and of lower signiﬁcance, reﬂect-
ing changes in biosynthetic processes, while the annotations
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Table 3
DAVID software analysis.
Annotation typea Kidney Score b p-Value c Lymph node Score p-Value
Up-regulated annotation
clusters
Antigen processing and
presentation
6.0 Cell division 6.2
Inﬂammatory response 5.8 Mitosis, cell cycle 2.8
Regulation of immune
response
5.3 Chemokines and receptors 2.4
Regulation of lymphocyte
mediated immunity
3.6 Autoimmune reaction 2.4
Regulation of lymphocyte
activation
3.5 Meiosis 2.0
Up-regulated KEGG
pathways
Antigen processing and
presentation
<0.0001 Meiosis 0.0001
Allograft rejection <0.0001 Graft-versus-host disease 0.0013
Graft-versus-host  disease <0.0001 Cell cycle 0.0018
Viral myocarditis <0.0001 Allograft rejection 0.0018
Cell adhesion molecules <0.0001 Cytokine-receptor interaction 0.0020
Down-regulated
annotation clusters
Short-chain
dehydrogenase/reductase
2.0 Cell adhesion 3.0
Follistatin-like proteins 2.5
Protein phosphatase binding 2.1
Embryonic development 1.5
Membrane organisation 1.4
Down-regulated KEGG
pathways/GO terms d
GO:0055114
oxidation-reduction
<0.0001 Cell adhesion molecules 0.001
GO:0045833 regulation of lipid
metabolic process
0.0047 Cardiomyopathy 0.005
GO:0005932 microtubule basal
body
0.0068
a Enriched annotation terms among genes with altered regulation (based on genes with pf < 0.01 and FC > 2 from the microarray analysis). In each annotation type the top
ﬁve  entries with score > 1 or p < 0.01 are shown.
b The signiﬁcance of enrichment was measured by the score, the geometric mean (−log) of the pf-values of the contributing genes, or by the p-value.
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d No signiﬁcant enrichment of genes in KEGG pathways was  seen among down-re
p  < 0.01) are given for this gene set.
orresponding to lymph node down-regulated genes included cell
dhesion, control of proliferation by follistatins as well as some
iosynthetic processes (Table 3).
It is clear from the observed pathology of MCF that non-
ymphoid organs experience a signiﬁcant inﬂux of lymphoid cells
including virus-infected cells) which contribute to lesion devel-
pment. Thus the annotation enrichment for kidney is likely to
eﬂect the transcriptional activity of activated lymphocytes that
re responsible for the observed pathology of MCF. Lymph node
yperplasia is a known element of MCF  pathology (Anderson et al.,
007; Buxton et al., 1984; Jacoby et al., 1988) and this is reﬂected
n the annotation enriched in this tissue. Thus the tissue-speciﬁc
ifferences in enriched annotation in response to MCF  may  reﬂect
oth disease-speciﬁc changes in gene expression and changing cell
opulations in the different tissues.
.5. Pathway analysis of differentially expressed genes
Differentially regulated pathways were also investigated using
ngenuity Pathway Analysis. Brieﬂy, pf and FC values associated
ith the entire dataset of lymph node and kidney were uploaded
o the IPA software for global analysis. Use of the entire dataset
llowed those genes with small but signiﬁcant changes in mean
xpression to contribute to the identiﬁcation of signiﬁcantly altered
ene groups and pathways. It also allows the background of genes
hat did not change in expression to contribute to the evaluation of
otentially signiﬁcant pathways. The main ﬁndings of this analysis
re summarised in Table 4.
This analysis also highlights differences between kidney and
ymph node gene expression patterns, especially in the networks,
isorders and pathways that were identiﬁed as having signiﬁ-
ant scores or p-values. The most signiﬁcant networks/disordersd genes in the kidney, so the most signiﬁcantly enriched gene ontology (GO) terms
identiﬁed included those associated with cancer and cell prolifera-
tion in the lymph node; and antigen presentation and inﬂammatory
responses in the kidney (Table 4). Indeed, across a range of analyses
performed with the IPA database (Table 4), there appears to be a
clear difference in the balance of transcriptional activity induced by
MCF. The lymph node sees changes in functions associated with cell
proliferation and growth regulation, while changes in the kidney
relate largely to increased immunological activity as well as prolif-
eration. Signiﬁcant up-regulation of pathways relating to immune
function is seen only in the kidney (antigen presentation; CD28
signalling; iCOS–iCOSL signalling; Natural Killer cell signalling),
identifying activated T lymphocytes and NK  cells as likely effectors
of tissue damage in MCF  (Table 4). Thus the observed transcrip-
tional changes in the kidney appear to reﬂect an increase in the
expression of activated lymphocyte phenotypes, while those in
the lymph node indicate strong proliferative activity, potentially
among resident lymphocytes.
4. Discussion
In this study, gene expression changes induced by AlHV-1
infection of a natural MCF-susceptible host (cattle) were analysed
using microarrays carrying probes for approximately 23,000 bovine
transcripts. Individual microarrays were used to interrogate RNA
samples from lymph node and kidney of multiple cattle. Kidney
was  chosen as a non-lymphoid tissue in which MCF  induces sub-
stantial lymphoid inﬁltration, forming visible lesions (Russell et al.,
2009), while the inclusion of lymph node tissue in the analysis was
intended to allow local changes in immune effector functions to
be distinguished from more general mitogenic changes that are a
consequence of lymphoproliferation. The use of both lymphoid and
non-lymphoid tissues, therefore, may  also aid the interpretation
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Table 4
Pathway analysis (IPA, based on all probesets).
Classiﬁcation Kidney Scorea pa Moleculesb Lymph node Score p Molecules
Top networks Cellular assembly and organisation; genetic disorder;
ophthalmic disease.
37 RNA post transcriptional modiﬁcation; protein synthesis;
small molecule biochemistry.
37
Antigen presentation; inﬂammatory response; genetic
disorder.
35 Cell cycle; developmental disorder; genetic disorder. 37
DNA  replication, recombination and repair; cellular
assembly and organisation; cell–cell signalling and
interaction.
35 Cancer; cell cycle; cellular growth and proliferation. 33
Amino acid metabolism; protein synthesis; small molecule
biochemistry.
31 Cellular movement; nervous system development and
function; cell morphology.
32
Cellular development; haematological system
development and function; haematopoiesis.
31 Protein trafﬁcking, RNA post-transcriptional modiﬁcation,
molecular transport.
32
Top  diseases/disorders Inﬂammatory response. 0.0006 217 Cancer. 0.021 659
Immunological disease. 0.0006 270 Genetic disorder. 0.020 247
Inﬂammatory disease. 0.0006 292 Respiratory disease. 0.001 113
connective tissue disorders. 0.0001 200 Gastrointestinal disease. 0.020 239
skeletal  and muscular disorders. 0.0002 275 Reproductive system disease. 0.020 367
Top  molecular functions Cellular growth and proliferation. 0.0005 254 Cell cycle. 0.021 291
Cellular  development. 0.0006 215 Cellular assembly and organisation. 0.014 79
Cellular  function and maintenance. 0.0005 136 DNA replication, recombination and repair. 0.019 164
Cell  death. 0.0004 292 Cellular movement. 0.020 191
Cell–cell  signalling and interaction. 0.0005 207 Antigen presentation. 0.014 33
Top  canonical pathways Antigen presentation. <0.0001 16/43 Mitochondrial dysfunction. <0.0001 42/169
CD28  signalling in Th cells. <0.0001 33/135 Protein ubiquitination pathway. <0.0001 66/274
iCOS–iCOSL signalling in T helper cells. <0.0001 27/125 Ubiquinone biosynthesis. <0.0001 26/119
Natural  Killer cell signalling. <0.0001 25/116 Mitotic roles of polo-like kinase. <0.0001 21/63
Systemic Lupus Erythematosus signalling. <0.0001 25/125 Cell cycle control of chromosomal replication. <0.0001 14/31
a The score (integer; negative log of respective IPA p-value) or maximum p-value assigned by the IPA software for each classiﬁcation is given. IPA uses a right tailed Fisher’s exact test to calculate p-values.
b The number of molecules with signiﬁcantly altered expression assigned to each classiﬁcation from the submitted gene lists or the number of genes/total number of molecules in pathway.
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f the data compared to the use of either individual tissue. The
bservation that more genes were found with signiﬁcantly altered
xpression due to MCF  in the kidney compared to lymph node sup-
orts the view that the kidney is an appropriate tissue in which to
eﬁne the effects of MCF  in cattle.
Initial analysis of the microarray results identiﬁed 35 genes
hose mean expression was signiﬁcantly increased in both MCF-
ffected tissues (Table 2A). These genes encode a range of proteins,
ncluding immunological effector molecules and chemokines.
loser examination of these highly expressed genes may  provide
lues to MCF  pathogenesis.
One group of up-regulated genes encoded cytotoxic effector
olecules. These included granulysin, granzyme H and perforin
GNLY, GZMH and PRF1; Table 2), while granzyme B (GZMB) was
ound to be up-regulated in kidney by microarray analysis and
n both tissues by qRT-PCR (supplementary Table S1,  Fig. 1). This
roup included the most highly up-regulated genes in both tissues,
nderlining their signiﬁcance in the generation of MCF  pathology.
Chemokine ligands formed another group of up-regulated
enes. CCL3, CCL4, CCL5 and CXCL11 were up-regulated in both
issues while CCL8, CCL19 and CXCL10 were up-regulated in kid-
ey. These are all pro-inﬂammatory chemokines that function by
ecruiting and activating T cells and other lymphocytes. In partic-
lar, CXCL10 and CXCL11 bind the receptor CXCR3 on activated
 cells to recruit them to peripheral sites. These chemokines and
heir receptor are associated with T cell trafﬁcking in a range of
nﬂammatory conditions and autoimmune diseases (Groom and
uster, 2011). They may  therefore play a role in the T cell inﬁl-
ration that appears to be a central feature of MCF  pathogenesis.
 CXCR3 antagonist compound has been shown to inhibit chemo-
axis and attenuate disease in a range of autoimmune models (Jenh
t al., 2012). MCF  can be viewed as a disease exhibiting similari-
ies to autoimmune pathogenesis that makes the CXCR3 receptor
nd its ligands interesting targets for future research and potential
herapies.
Several of the genes in Table 2A are inducible by IFN (e.g. CCL3,
CL4, CCL5, CXCL11, IDO, UBD), suggesting that this may  be a com-
on  factor underlying the pathogenesis of MCF. IFN itself was
p-regulated by over 3-fold in the tissues analysed here (Table 2),
upporting the view that it may  be responsible for many of the
xpression changes observed. Indeed, aberrant expression of IFN
as been associated with inﬂammatory and autoimmune diseases
Schoenborn and Wilson, 2007).
A previous microarray analysis of gene expression in MCF-
ffected lymph node from OvHV-2 infected cattle (Meier-Trummer
t al., 2009a)  showed that IL-2 expression was  reduced in
CF-affected lymph node and suggested this might be a key
o understanding MCF  pathogenesis. This observation was con-
rmed by qPCR studies in AlHV-1 infected rabbits (Dewals and
anderplasschen, 2011), that also detected up-regulation of IFN,
erforin and IL-10, suggesting that the pathology of MCF was  simi-
ar in rabbits infected with either of the major MCF  viruses. The data
resented here in AlHV-1-infected cattle conﬁrmed the increased
xpression of pro-inﬂammatory cytokines and cytotoxic effectors
n MCF  (Table 2), but provided no evidence for changes in expres-
ion of IL-2 or IL-10.
This could reﬂect a genuine difference in AlHV-1-infected cat-
le compared to OvHV-2-infected cattle, or MCF-affected rabbits.
lternatively, the expression differences observed may  reﬂect
he challenge system used in this work, since MCF  induced by
ntranasal challenge has a longer incubation time than intra-
enous challenge (Haig et al., 2008) and the animals used here
ere euthanised at a relatively early clinical stage due to welfare
equirements. Thus the load of infected cells in these tissues may
ave been lower than that in tissues used in previous work. Cur-
ently there is no simple, robust way of detecting and analysingch 169 (2012) 246– 254 253
virus-infected cells in the tissues of MCF-affected animals. Recent
work using a recombinant MCF  virus expressing luciferase illus-
trates one approach with the potential to address this issue in
experimental systems (Dewals et al., 2011). In addition, we  have
recently identiﬁed a novel gene in AlHV-1 and detected its mRNA
in MCF  lesions by RT-PCR and in situ hybridisation (G.C. Russell
et al., unpublished data). This may  be a useful tool for the analysis
of infected cell frequencies in the tissues.
Gene ontology and pathway analysis (Tables 3 and 4) suggested
that immunological and inﬂammatory processes were increased in
kidney compared with increased cell proliferation and trafﬁcking in
the lymph node. Non-reactive lymph node is likely to contain trans-
cripts related to normal immunological processes, while kidney is
not, so that transcription from lymphocytes recruited to the kidney
as part of MCF  pathogenesis is likely to make a greater impact on
the pattern of gene expression than in the lymph node. However,
the increased expression of cytotoxic effector genes and chemokine
genes in the lymph node demonstrates that immunological dysreg-
ulation occurs in this tissue too, reﬂected in the observed lymph
node pathology. This is in accord with reports that cytotoxic CD8 T
lymphocytes inﬁltrate and proliferate in MCF  lesions of bison and
rabbits (Dewals and Vanderplasschen, 2011; Nelson et al., 2010)
and that many of these cells are likely to be infected (Dewals et al.,
2011; Dewals and Vanderplasschen, 2011).
The activities of the gene products over-expressed in both ana-
lysed tissues of the MCF-affected animals suggest that constitutive
expression of inﬂammatory genes may  contribute to the pathology
of MCF  (Table 2) with overexpression of IFN playing an impor-
tant role. Thus, virus-infected lymphocytes, disseminated via the
circulation to multiple organs, may  act through expression of IFN-
induced CXC and CC cytokines to recruit activated cytotoxic T cells
to peripheral sites. We  can speculate that the expression of high
levels of cytotoxic effector molecules by virus-infected and/or unin-
fected cells in MCF-affected tissues generates a non-speciﬁc T cell
cytotoxicity that leads to tissue damage.
Interestingly, infected large granular lymphocyte (LGL) lines
that can be established from tissues of MCF-affected animals
have non-MHC-restricted cytotoxic activity, are known to express
pro-inﬂammatory cytokines and have constitutively active Lck and
Fyn kinase pathways (Anderson et al., 2008; Schock et al., 1998;
Swa  et al., 2001). These cell lines have been suggested to represent
the infected cells in vivo. The microarray data presented here adds
further evidence for a connection between the phenotype of LGL
lines and MCF  pathogenesis. Strong evidence of cytotoxic activity,
activated T cell signalling and the up-regulation of IFN expression
are seen both in the LGLs and in MCF-affected cattle tissues (Schock
et al., 1998; Swa et al., 2001).
In conclusion, this study of AlHV-1 induced MCF  in cattle, a
naturally susceptible host, conﬁrms the results of previous stud-
ies of MCF  in rabbits or OvHV-2-infected cattle with respect to a
possible role for increased cytotoxicity, and for IFN-stimulated
immune and inﬂammatory responses, but differs with respect to
IL-2 depression. This requires further analysis, including assays to
conﬁrm that changes in mRNA expression are reﬂected at the level
of protein expression and activity. The expression of up-regulated
genes, such as GNLY, CXCL11, UBD or IFN, in MCF-virus-infected
cells also warrants further study in order to clarify their role in
pathogenesis—whether they act directly to initiate tissue damage
via cytotoxic activity or indirectly by recruiting and activating cyto-
toxic T cells at lesion sites.
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